dansylglutamyl-glycyl-arginine chloromethyl ketone has been researched along with epidermal growth factor in 1 studies
| Studies (dansylglutamyl-glycyl-arginine chloromethyl ketone) | Trials (dansylglutamyl-glycyl-arginine chloromethyl ketone) | Recent Studies (post-2010) (dansylglutamyl-glycyl-arginine chloromethyl ketone) | Studies (epidermal growth factor) | Trials (epidermal growth factor) | Recent Studies (post-2010) (epidermal growth factor) |
|---|---|---|---|---|---|
| 31 | 0 | 0 | 24,155 | 217 | 4,699 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brinkhous, KM; Chang, JY; Monroe, DM; Roberts, HR; Stafford, DW | 1 |
1 other study(ies) available for dansylglutamyl-glycyl-arginine chloromethyl ketone and epidermal growth factor
| Article | Year |
|---|---|
Replacing the first epidermal growth factor-like domain of factor IX with that of factor VII enhances activity in vitro and in canine hemophilia B.
Topics: Amino Acid Chloromethyl Ketones; Animals; Dansyl Compounds; DNA, Recombinant; Dogs; Epidermal Growth Factor; Factor IX; Factor IXa; Factor VIIa; Factor VIIIa; Factor Xa; Factor Xa Inhibitors; Factor XIa; Hemophilia B; Humans; Partial Thromboplastin Time; Recombinant Fusion Proteins | 1997 |